[1] Weiβ J, Rau M , Geier A . Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int, 2014, 111(26):447. [2] 田军伟,肖远力,王艳超. 应用血清TG/HDL-C比值早期诊断非酒精性脂肪性肝病患者临床价值探讨. 实用肝脏病杂志,2017,20(4):416-419. [3] Højland Ipsen D, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci,2018,75(18): 3313-3327. [4] Mohamed A, Lounis, Karl F, et al. Oleate activates SREBP-1 signaling activity in SCD1- deficient hepatocytes. Physiol Endocrinol Metab, 2017, 313(6): 710-720. [5] Ren TT, Zhu JJ, Zhu LL, et al . The combination of blueberry juice and probiotics ameliorate non-alcoholic steatohepatitis by affecting SREBP-1c/PNPLA-3 pathway via PPAR-α. Nutrients,2017, 9(3): 198. [6] 池肇春.非酒精性脂肪性肝炎肝硬化发病机制研究进展与展望. 实用肝脏病杂志,2018,21(2):166-169. [7] Zhang X, Ji XT, Wang Q, et al . New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell, 2018, 9(2): 164-177. [8] Kucera O, Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol, 2014, 20(26): 8364-8376. [9] He Q, Li JK, Li F, et al . Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol, 2015,21(7): 2058-2066. [10] Sohair M, Raga B, Sary KH, et al . Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. Lipids Health Dis, 2015, 14: 83. [11] Meng Y, Liu Y, Fang NN, et al . Hepatoprotective effects of cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat. Pharm Biol,2019, 57(1): 98-104. [12] Miyata S, Inoue J, Shimizu M, et al. Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation. Biol Chem, 2015,290(33): 20565-20579. [13] Kuan YC, Hashidume T, Shibata T, et al. Heat shock protein 90 modulates lipid homeostasis by regulating the stability and function of sterol regulatory element-binding protein (SREBP) and SREBP cleavage-activating protein. Biol Chem, 2017, 292(7): 3016-3028. [14] Jelenik T , Kaul K , Séquaris G, et al. Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver. Diabetes, 2017, 66(8):2241. [15] Birgit K , Sonja H , Sylvia J , et al. Inactivation of SREBP-1a phosphorylation prevents fatty liver disease in mice: identification of related signaling pathways by gene expression profiles in liver and proteomes of peroxisomes. Int J Mol Sci, 2018, 19(4):980. [16] Ito M, Nagasawa M, Omae N, et al. A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes. Lipid Res, 2013, 54(6): 1531-1540. [17] Torres JL, Novo-Veleiro I, Manzanedo L, et al. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol, 2018, 24(36): 4104-4118. [18] Shu ZP, Gao Y, Zhang GP, et al. A functional interaction between Hippo‐YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice. Cell Mol Med, 2019, 23(5): 3616-3628. [19] Wang CM, Yuan RS, Zhuang WY, et al. Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice. Lipids Health Dis, 2016, 15: 195. [20] Shen L, Cui AF, Xue Y, et al. Hepatic differentiated embryo-chondrocyte expressed gene 1 inhibits sterol regulatory element-binding protein-1c expression and alleviates fatty liver phenotype. Biol Chem, 2014, 289(34): 23332-23342. |